Status:
COMPLETED
EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up
Lead Sponsor:
Imperial College London
Conditions:
Covid19
Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
TITLE EARSATS-19: In-ear measurement of blood oxygen saturation in COVID-19 follow up DESIGN Non-inferiority study AIMS To evaluate qualitative and quantitative performance of in-ear SpO2 monitoring...
Detailed Description
Non-invasive ambulatory estimation of blood oxygen saturation (SpO2) has emerged as an important clinical requirement to detect hypoxia (low blood oxygen) in the delayed post-infective phase of COVID-...
Eligibility Criteria
Inclusion
- Patients attending respiratory clinic either for COVID-19 follow up or for chronic lung disease.
- Able to give informed consent (where not able to use CIE, paper consent form will be made available)
Exclusion
- Abnormal ear canal anatomy
Key Trial Info
Start Date :
August 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04529408
Start Date
August 26 2020
End Date
August 10 2022
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, Non-US/Non-Canadian, United Kingdom, E5 0LJ